# Haploinsufficiency of the RBM22 and SLU7 Genes in Del(5q) Myelodysplastic Syndromes

> **NCT04701229** · — · UNKNOWN · sponsor: **University Hospital, Brest** · enrollment: 100 (estimated)

## Conditions studied

- Myelodysplastic Syndromes
- Myelodysplastic Syndrome With Isolated Del(5Q)
- Myelodysplastic Syndrome With Del(5Q)

## Interventions

- **GENETIC:** somatic cytogenetic and genetic characterization

## Key facts

- **NCT ID:** NCT04701229
- **Lead sponsor:** University Hospital, Brest
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-30
- **Primary completion:** 2022-09-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04701229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04701229, "Haploinsufficiency of the RBM22 and SLU7 Genes in Del(5q) Myelodysplastic Syndromes". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT04701229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*